Innovus Pharmaceuticals Reports Preliminary Q1 2019 Sales Revenue of Approximately $5.4 million

On May 6, 2019 Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), reported preliminary first quarter 2019 net revenue is estimated to be $5.4 million or an approximate 12.8% increase from the fourth quarter of 2018 and 18.0% increase from the first quarter of 2018 (Press release, Innovus Pharmaceuticals, MAY 6, 2019, View Source [SID1234535765]). Innovus Pharma’s first quarter 2019 anticipated revenue results are preliminary and based on the most current information available and are subject to completion of the condensed consolidated financial statements for the first quarter of 2019, which are to be filed with the SEC no later than May 15, 2019.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"We continue to execute on our controlled growth and profitability plan with focusing our growth in profitable sales channels only," stated Bassam Damaj, President and Chief Executive Officer of Innovus Pharma. "The market should also expect to see a more robust ANDA OTC pipeline very soon," continued Dr. Damaj.

The Company will host a conference call on Wednesday, May 15, 2019 at 4:15 p.m. ET/1:15 p.m. PT to discuss the financial results and recent business developments. To participate in the call, please dial 1-877-883-0383 for domestic callers or 1-412-902-6506 for international callers or 1-877-885-0477 for Canadian callers. Participant Elite Entry Number: 0678670. A replay of the call will be available for 30 days. To access the replay, dial 1-877-344-7529 domestically or 1-412-317-0088 internationally or 1-855-669-9658 for Canada and reference Replay Access Code: 10131471. The replay will be available shortly after the end of the conference call